Cabot (NYSE:CBT) Receives New Coverage from Analysts at Mizuho

Mizuho started coverage on shares of Cabot (NYSE:CBT) in a report released on Wednesday morning, Marketbeat.com reports. The firm issued a buy rating and a $104.00 price objective on the specialty chemicals company’s stock.

Several other equities analysts have also recently commented on the stock. StockNews.com cut shares of Cabot from a strong-buy rating to a buy rating in a research report on Wednesday, February 14th. UBS Group cut shares of Cabot from a buy rating to a neutral rating and dropped their target price for the company from $90.00 to $87.00 in a research report on Monday, January 8th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of Moderate Buy and an average price target of $87.67.

Cabot Price Performance

Shares of Cabot stock opened at $91.86 on Wednesday. Cabot has a twelve month low of $63.73 and a twelve month high of $91.96. The company has a quick ratio of 1.30, a current ratio of 2.04 and a debt-to-equity ratio of 0.74. The company has a 50-day simple moving average of $82.00 and a two-hundred day simple moving average of $76.79. The stock has a market capitalization of $5.09 billion, a price-to-earnings ratio of 11.93, a price-to-earnings-growth ratio of 0.95 and a beta of 1.27.

Cabot (NYSE:CBT) last issued its earnings results on Monday, February 5th. The specialty chemicals company reported $1.56 EPS for the quarter, beating the consensus estimate of $1.49 by $0.07. The company had revenue of $958.00 million during the quarter, compared to analysts’ expectations of $927.28 million. Cabot had a net margin of 11.24% and a return on equity of 25.52%. Analysts forecast that Cabot will post 6.58 EPS for the current year.

Cabot Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 8th. Investors of record on Friday, February 23rd were issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.74%. The ex-dividend date was Thursday, February 22nd. Cabot’s dividend payout ratio (DPR) is presently 20.78%.

Insider Activity at Cabot

In related news, EVP Jeff Ji Zhu sold 55,233 shares of Cabot stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $79.91, for a total transaction of $4,413,669.03. Following the sale, the executive vice president now directly owns 97,201 shares of the company’s stock, valued at approximately $7,767,331.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 3.07% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Cabot

A number of institutional investors have recently added to or reduced their stakes in CBT. EverSource Wealth Advisors LLC grew its holdings in Cabot by 143.1% during the 4th quarter. EverSource Wealth Advisors LLC now owns 333 shares of the specialty chemicals company’s stock worth $28,000 after acquiring an additional 196 shares during the last quarter. Parkside Financial Bank & Trust grew its holdings in Cabot by 176.0% during the 1st quarter. Parkside Financial Bank & Trust now owns 414 shares of the specialty chemicals company’s stock worth $28,000 after acquiring an additional 264 shares during the last quarter. Arlington Trust Co LLC bought a new stake in Cabot during the 4th quarter worth approximately $34,000. Hexagon Capital Partners LLC grew its holdings in Cabot by 81.8% during the 4th quarter. Hexagon Capital Partners LLC now owns 460 shares of the specialty chemicals company’s stock worth $38,000 after acquiring an additional 207 shares during the last quarter. Finally, SRS Capital Advisors Inc. grew its holdings in Cabot by 372.0% during the 4th quarter. SRS Capital Advisors Inc. now owns 505 shares of the specialty chemicals company’s stock worth $42,000 after acquiring an additional 398 shares during the last quarter. 93.18% of the stock is owned by institutional investors.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.